We are live on ! Find out more
FCMI

Foresite Capital Management IV Portfolio holdings

AUM $237M
1-Year Est. Return 107.53%
This Fund
S&P 500
This Quarter Est. Return
-9.86%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$234M
AUM Growth
-$76.8M
Cap. Flow
+$4.31M
Cap. Flow %
1.84%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SNDX icon
Syndax Pharmaceuticals
SNDX
+$4.31M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNTE
1
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$59M 25.2%
9,671,643
– –
ACRS icon
2
Aclaris Therapeutics
ACRS
$726M
$44.2M 18.89%
2,808,034
– –
PHVS icon
3
Pharvaris
PHVS
$2.28B
$36.5M 15.6%
3,246,926
– –
LYEL icon
4
Lyell Immunopharma
LYEL
$317M
$34.7M 14.82%
500,000
– –
KURA icon
5
Kura Oncology
KURA
$800M
$23M 9.81%
1,849,947
– –
SNDX icon
6
Syndax Pharmaceuticals
SNDX
$1.69B
$22.3M 9.51%
875,000
+185,000
+27% +$4.31M
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$11.2M 4.79%
1,787,094
– –
QSI icon
8
Quantum-Si Incorporated
QSI
$155M
$3.24M 1.38%
1,771,249
– –

Similar funds

BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return
AG
ASO Group Road Town $237M AUM
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
MFA
Millington Financial Advisors Naperville, Illinois $237M AUM 22.22% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
CB
CNB Bank Clearfield, Pennsylvania $238M AUM 26.55% 1-Year Est. Return

Foresite Capital Management IV's Q4 2022 Portfolio in Review

As of Q4 2022, Foresite Capital Management IV held 8 positions worth $234M, down 25% from $311M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Foresite Capital Management IV opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management IV added most to Syndax Pharmaceuticals in Q4 2022, an estimated $4.31M increase.
  • Foresite Capital Management IV's ten largest holdings make up 100% of its $234M portfolio in Q4 2022.
  • Foresite Capital Management IV opened 0 new positions and closed 0 in Q4 2022.
  • Foresite Capital Management IV's portfolio value fell 25% quarter-over-quarter to $234M.

Based on Foresite Capital Management IV's 13F filing for Q4 2022, filed 13 Feb 2023.